drugset / Trial / NCT03527381

Nitric Oxide in Cardiopulmonary Bypass for Renal Protection in Cardiac Surgery

NCT03527381

Phase 1/2 Completed 96 enrolled Nikolay Kamenshchikov
RandomizedParallel-groupTriple-blindPrevention

Summary

This prospective randomized study evaluates the nephroprotective effects of exogenous nitric oxide delivered to the extracorporeal circulation circuit during cardiac surgery with cardiopulmonary bypass.

Timeline

Start
2015-09-01
Primary completion
2016-12-25
Completion
2017-04-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitric Oxide Other / unclassified 40 ppm Other